Introduction
Methyl Chloride (MeCl; Chloromethane; CH 3 Cl; CAS 74-87-3), a highly flammable colorless gas, belongs to the family of chlorinated methanes, e.g., carbon tetrachloride, chloroform, and methylene chloride, for which there is an extensive toxicology database demonstrating similarities and differences. All behave as electrophiles and consequently interact with the in vivo glutathione (GSH) pool.
MeCl is a high production volume chemical (> 1000 t/a), with current global industrial production estimated to be about 3.5 million t/ a, of which about 36% is produced in Europe. Historically it was used for production of tetramethyl lead and as refrigerant R 40; however, these uses were abandoned decades ago for technical (reactivity with aluminum) and safety (high flammability) reasons. Under the EU REACh regulation, the producers of MeCl explicitly advise against uses as a refrigerant and by consumers (e.g., propellant in hairspray cans), in accordance with their long-standing Responsible Care ® commitments.
Current industrial applications for MeCl include uses as an intermediate, in particular for the production of methyl cellulose, silicone resins, higher chlorinated methanes, agrochemicals, water treatment chemicals, pharmaceuticals, surfactants, and to a minor extent, use as cryogenic solvent in the production of butyl rubber. Given its high flammability, and necessary pressurized storage and transport in a liquefied state, safe handling requires that MeCl be maintained in closed systems throughout its entire life cycle to prevent emissions and avoid worker exposure. Although necessarily strictly controlled during industrial manufacture and use, MeCl is the most abundant halocarbon in the atmosphere (Verhulst et al., 2013) . In addition to industrial production, MeCl is also naturally formed in very large amounts by biological and chemical processes, including tropical plants, wood-rotting fungi, marine phytoplankton, oceanic processes (sunlight on biomass/ sea foam), and by coastal/salt marsh ecosystems, among other natural sources -including humans who off-gas endogenously produced MeCl (Keppler et al., 2005 (Keppler et al., , 2017 Xiao et al., 2010) . MeCl emissions also come from natural and anthropogenic combustion processes (e.g., biomass burning, forest fires, cigarette smoke, automobile exhaust, incineration). In fact, about 95% of atmospheric MeCl is estimated to stem from natural sources (Keppler et al., 2005; Xiao et al., 2010) , with all anthropogenic sources (coal combustion, incineration, industrial) accounting for only 5.4% (Xiao et al., 2010) . As expected for a high production volume chemical, MeCl has a large body of toxicology data available, both from accidental/incidental human exposures and from many short-term through chronic animal studies (ATSDR, 1998; US EPA, 2001) . MeCl is readily absorbed by the lungs following inhalation exposure and widely distributed in the body. Glutathione (GSH)-based metabolism can result in formation of the toxic metabolite methanethiol which can be further metabolized by cytochromes P450 (CYP450) to formaldehyde. Acute toxic effects noted in humans following accidental/incidental high exposures to MeCl focused on neurological, central nervous system (CNS) effects, such as drowsiness, dizziness, nausea, and ataxia, with potential for respiratory paralysis, seizures, and coma at very high exposures, and subsequent pulmonary edema, which can be fatal. Longer term exposures in lab animals have resulted in brain, liver, kidney, and testicular effects, depending on the animal species. Male rats demonstrated testicular atrophy after long-term exposure to high levels of MeCl while certain mouse-specific effects are thought to be due to mouse-specific metabolism. For example, mouse-specific brain effects are mediated by a murine glutathione-S-transferase (GST) in brain, while metabolism via murine isoforms of CYP450 resulted in male mouse-specific effects in kidney (MAK Commission, 1992; Dekant et al., 1995) . Chronic inhalation exposure to 1000 ppm MeCl induced kidney tumors in male mice, but no increases in tumors were noted in female mice or in male or female rats (Pavkov et al., 1982; unpublished report) . An OEL of 20 ppm MeCl as an 8-h TWA has been recommended by SCOEL (2016) , based on testicular effects in rats and consideration of data on human exposure; neither the male mouse kidney tumors nor the weak in vitro only evidence for genotoxicity were considered relevant. Recently, the EU Advisory Committee on Safety and Health at Work (ACSH) also proposed an OEL of 20 ppm (ACSH, 2018) ; this ACSH opinion is expected to be taken into account by the EU Commission when proposing its 5th list of IOELVs for inclusion in the Chemical Agents Directive (Directive 98/24/EC).
Several animal studies have been conducted with MeCl to determine its potential to induce developmental effects from in utero exposures. In the early developmental toxicity studies heart effects were reported in mice; these effects were not found in similarly treated rats (WolkowskiTyl et al., 1983a) . In follow-up work in mice, some similar cardiac defects were reported but at much lower incidences (Wolkowski-Tyl et al., 1983b) . Additional work in a different lab did not reproduce the mouse-specific cardiac effects (John-Greene et al., 1985) . Thus, the effects reported in mice did not occur in rats and were not well replicated in a follow-up study, and were not reproduced in a different lab. Such a contradictory, non-reproducible data set introduces considerable uncertainty in drawing any conclusions on hazard or risk, especially vis-à-vis regulatory decisions.
Indeed, several regulatory/expert groups have reviewed the thenavailable database on mice and rats to determine an appropriate classification of MeCl vis-à-vis its potential to induce developmental toxicity. One group of European hazard classification experts (the Working Group "Classification and labelling of dangerous substances") met in 1987 to evaluate the data of MeCl. They concluded that "… the majority agreed that the questionable heart defects found in mouse embryos do not justify classification as teratogen …" (cited from the minutes of the 1987 meeting in Brussels). Similarly, the Dutch Health Council reviewed in 2004 the same studies in rats and mice mentioned above (Dutch Health Council, 2004 ). They recommended not classifying MeCl with respect to developmental toxicity based on a lack of appropriate data. Apparently, they did not consider the mouse data to be of sufficient evidence. However, the German MAK Commission (1992) (German Committee for the determination of occupational exposure limits) classified MeCl in pregnancy risk group B 'damage to the embryo or fetus cannot be excluded after exposure to concentrations at the level of MAK and BAT value'. The US EPA (2001) concluded in its Integrated Risk Information System (IRIS) program assessment of MeCl toxicity that, in the absence of additional data to clarify the uncertainties, MeCl should prudently be considered a mouse teratogen.
Based on the data reported for mice in registering MeCl in the EU under REACh in 2010, the MeCl REACh Consortium decided to selfclassify MeCl for developmental toxicity as GHS/CLP category 2 (H361: Suspected of damaging fertility or the unborn child), applying precautionary principles. In view of the overall MeCl toxicity profile (GHS/ CLP classification: Repro cat. 2, STOT RE cat. 2, Carcinogen cat. 2), the Consortium considered at that time that any attempt at further clarification of the apparent mouse-specific developmental toxicity, which would require additional animal experiments to elucidate, would not be ethical, given the other significant toxicity classifications already in place for this highly controlled industrial chemical. As the effects identified in the non-standard species mouse would still be present and still lead to an overall ambiguous picture, self-classification offered a pragmatic and ethical animal-sparing approach, with no additional data collection planned.
However, MeCl was included in the on-going European CoRAP program, and that review resulted in the Member State Committee's (MSC) determination that the existing database with rats and mice was insufficient for a hazard evaluation of developmental toxicity potential for this high tonnage chemical. Thus, based on the high tonnage, the MSC required the conduct of an OECD 414 study in a non-rodent species (rabbit) to clarify the species-specificity and potentially the mode of action of MeCl developmental toxicity. That new dataset is now available, and this report integrates the new non-rodent dataset into an overall weight-of-evidence assessment of all the available data and existing uncertainties to provide a final conclusion on the developmental toxicity potential of MeCl.
In the following sections a brief overview will be given on the rat and mouse studies, as well as the recently conducted, GLP OECD 414 guideline study in rabbits.
Studies conducted to evaluate potential developmental toxicity of MeCl
One study published by Wolkowski-Tyl et al. (1983a) evaluated both mice and rats and reported significant study details, including information on test material purity, chamber atmosphere generation and chamber distribution testing. The details described indicated this study design was similar to an OECD 414 guideline approach. The second Wolkowski-Tyl et al. study (Wolkowski-Tyl et al., 1983b) focused on mouse cardiac effects but also included detailed descriptions of study design and exposure-related parameters. The work conducted by John-Greene et al. (1985) was not described in equivalent detail and was more of a mode-of-action study design comprised of several single exposure level experiments, focused on the evaluation of cardiac effects induced by MeCl exposure of mice during the critical window for cardiac development (gd 11.5-12.5) and any related biological variability. The rabbit developmental toxicity study (Theuns-van Vliet, 2016) was conducted under GLP as an OECD 414 guideline study, and the study report includes all the required detailed description of test material and exposure conditions, and all other parameters. For simplicity, a brief description of each of these studies and their results follows, divided into species-specific sections on rat, mouse, and rabbit. in groups of 25 pregnant Fischer 344 rats following inhalation exposure to 0, 100, 500, or 1500 ppm (corresponding to 0, 205, 1025, or 3075 mg/m 32 ), 6 h/day daily, from gestation day (gd) 7 through gd 19. On gd 20, dams were sacrificed and reproductive and fetal parameters evaluated. Although no reproductive parameters were significantly affected by exposure to MeCl, rat dams from the highest concentration group demonstrated some maternal toxicity as evidenced by reductions in body weight, body weight gains, and food consumption. Statistically significant reductions in male and female fetal body weight and in female fetal crown-to-rump length were identified for the 1500 ppm group; however, these effects were considered secondary to maternal toxicity by the authors. In line with these observations, there were indications of skeletal immaturities such as statistically increased incidences in delayed ossification. No teratological malformations were observed. Based on these results, the No-Observed-Adverse-EffectConcentration (NOAEC) for maternal toxicity in rats was determined to be 500 ppm and the NOAEC for teratogenicity in rats was ≥1500 ppm.
Studies in mice
As part of the study described above, Wolkowski-Tyl et al. (1983a) exposed groups of 33 pregnant mice to 0, 100, 500, or 1500 ppm (0, 205, 1025, or 3075 mg/m 3 ) MeCl 6 h/day daily on gd 6-17. Female C57BL/6 mice were bred to C3H males, producing B6C3F1 offspring. Due to severe toxicity, consisting of urogenital bleeding and severe CNS dysfunction, all the high concentration group mice were humanely sacrificed between gd 10-14. Prior to necropsy, two dams died; necropsy of these high concentration group dams revealed necrosis of neurons in the internal granular layer of the cerebellum, a recognized mousespecific effect of MeCl exposure. The remaining groups (0, 100, and 500 ppm) were necropsied as scheduled on gd 18; no maternal toxicity was reported based on the limited parameters of food and water intake, and body weight/body weight gain. No reproductive parameters were significantly affected by exposure to MeCl. Mean fetal body weight and fetal crown-rump length were slightly, but not statistically significantly, increased in both male and females for the exposed animals. No treatment-related external or skeletal effects were observed. Half of each litter underwent visceral examination as Bouin's-fixed fetuses according to Wilson (1965) , using cross sections. This evaluation identified a statistically significant increase in the incidence of (combined) heart effects in the 500 ppm group, observed in 6 of 17 litters and representing 16.65 ± 7.14% of fetuses (Table 1) . Both males and females were affected (3 males and 6 females) with no single fetus having both sides of the heart involved. One litter had right-and left-side involvement, and 5 of the 6 affected litters also had fetuses with normal-appearing hearts. The defects were further characterized as typically involving a hypoplastic tricuspid valve, appearing off-center and malformed, and were associated with a much thinner right heart wall and a thickening of the septal side of the ventricle. The lesions involved either the bicuspid or mitral valve on the left atrioventricular septum (3 fetuses), or the tricuspid valve, or chordae tendineae, or papillary muscles (6 fetuses) on the right, thus 9 in total, summarized as a reduction or absence of the atrioventricular valves, reduction or absence of chordae tendineae, and/or reduction or absence in papillary muscles. No details were provided on the numerical distribution of these effects; not on the type nor in which animals. The authors concluded that gestational exposure to 500 ppm MeCl was teratogenic in mice.
To further explore this effect, additional data were collected with a larger number of MeCl-exposed dams in a similar study design but focused on heart lesions and applying a 'blinded' approach to fetal heart evaluation (Wolkowski- Tyl et al., 1983b) . Mated female mice (74-77/ group; as before, female C57BL/6 mice bred to C3H males producing B6C3F1 offspring) were exposed to MeCl at 0, 250, 500, or 750 ppm (0, 513, 1025, or 1538 mg/m 3 ), 6 h/day daily on gd 6-17, and sacrificed on gd 18. From the seventh day of exposure (gd 12), mouse dams exposed to 750 ppm displayed ataxia, tremors, convulsions, and hypersensitivity to touch and sound. Six females in this group (8%) died and one was humanely sacrificed. The survivors in this group showed a statistically significantly decreased body weight and body weight gain on gd 18 when compared to controls, and a reduced absolute weight gain (weight gain minus gravid uterine weight). Despite the evidence for maternal toxicity from repeated exposure to 750 ppm MeCl, including mortality, no treatment-related effects were observed on pregnancy rate, gravid uterine weight, maternal liver weight, number of implantations, resorptions, dead fetuses, live fetuses, sex ratio, or mean fetal body weight. Fetuses were examined for external and visceral abnormalities, the latter according to Staples' fresh tissue dissection method (Staples, 1974) , instead of Bouin's fixed tissues as was done in the previous study. The authors reported a statistically significant and concentration-related effect on the total incidence of affected fetuses. All lesions but one (an umbilical hernia in the 250 ppm group) were observed in the heart (Table 2) . At 750 ppm both the number of fetuses affected and of litters with affected fetuses were statistically significantly increased. The only statistically significant change at 500 ppm (Chi-square test) consisted of an increase in the total number of fetuses with heart effects (11/444 versus 3/433 in controls), as neither the number of fetuses affected per litter (0.18 versus 0.05 in controls) nor the percentage of fetuses affected per litter (3.48% versus 0.68% in controls) were statistically significant at 500 ppm (Table 3) . No statistically significant effects were observed at 250 ppm. The authors reported that abnormalities of the heart were observed in all the groups, including the control. These included a reduction in the number of papillary muscles and/or chordae tendineae on the right-side associated with the tricuspid valve; the 750 ppm group had a statistically significant increased incidence of reduced number of papillary muscles on the right-side. In addition, at least one globular heart (heart rounded with no discernible apex) was observed in each exposure group, including the control; and a total of 5 fetuses in the two highest exposure groups had white spots (white crystalline deposit) on the left ventricular wall. One fetus in both the 500 and 750 ppm group exhibited a small right ventricle, and an absent or abnormal tricuspid valve was seen in one 250 ppm and one 750 ppm fetus. However, most of these findings were either of very low incidence, seen in single animals, and/ or were scattered amongst the groups (including controls) except for one observation, i.e., a non-statistically significant increase in the incidence of a reduction in the number of papillary muscles (Table 2; shown in bold), a finding which also occurred in controls. The authors concluded that MeCl was maternally toxic at 750 ppm and teratogenic at 500 and 750 ppm, causing cardiac malformations; 250 ppm was identified as a NOAEC. A summary comparison of results from the two mouse studies (Wolkowski-Tyl et al., 1983a,b) ), as reported by Tyl (1985) , is provided in Table 3 .
In a series of experiments to further explore the reported MeCl-induced developmental cardiac effects in mice and to understand its reproducibility and associated variability, John-Greene et al. (1985) developed a shortened protocol. They exposed pregnant C57BL mice, carrying B6C3F1 mice, to 250 or 300 ppm (513 or 615 mg/m 3 ) MeCl for 24 h (continuous) on gd 11.5 through gd 12.5 (gd 11.5-12.5 is considered the critical period for development of the embryonal heart in mice), after demonstrating that 350 ppm was lethal to some of the pregnant females for such a 24-h exposure. The evaluation of the fetuses from dams exposed to 250 ppm for 24 h was first done with hearts fixed in Bouin's according Wilson's technique. With fixed hearts, 6 of 7 litters and 13 of 49 fetuses (26.5%) were identified as having partial or complete absence of papillary muscles associated with the tricuspid valve. However, the authors also indicated that the technique of making cuts through the small, friable Bouin's-fixed tissue of the fetal hearts was unsatisfactory. In subsequent experiments, fresh fetal hearts were examined according to Staples (1974) , as was used for Wolkowski -Tyl et al. (1983b) . In the first phase, when 'blinding' was not applied, 12 litters from dams exposed to 300 ppm for 24 h and 11 control litters were evaluated for cardiac effects using the fresh tissue technique (Staples, 1974) . In the first litters examined, heart effects were seen but, as experience was gained, the effect of treatment on the papillary muscles was no longer evident. This prompted institution of 'blind' examination of the hearts, which then failed to reveal either an absence or a reduction in number of the papillary muscles of the tricuspid valve in a further 7 exposed litters and 5 control litters, all evaluated 'blinded'. In addition, as exposure to 1000 ppm (2050 mg/m 3 ) MeCl was tolerated for 12 h, pregnant mice were also exposed to 1000 ppm MeCl for 12 h on gd 11.5 to 12.0. No treatment-related heart lesions were observed in 6 exposed litters following those 12-h exposures. After examination of a total of 48 litters, these authors concluded that there was considerable inter-animal variability in the appearance of these cardiac papillary muscles, and that their small size, and the very precise and delicate dissection technique necessary to view them, rendered any confirmation of their presence or number a significant challenge. Thus, these authors raised concern in particular around the significance of any conclusion vis-à-vis the eventual relevance of these non-reproducible fetal mouse heart lesions for human risk assessment.
Study in rabbits
In a recently performed OECD 414 guideline, GLP study (Theunsvan Vliet, 2016) , New Zealand White rabbits were exposed daily to MeCl in whole body exposure chambers for 6 h/day at concentrations of 0, 250, 500, or 1000 ppm (0, 513, 1025, or 2050 mg/m 3 ) MeCl on gd 6-28. Exposure concentrations were based on two datasets: a study in which rabbits were exposed to MeCl 6 h/day, 6 d/wk, where the LT50 was 23 days of exposure to 2000 ppm, 192 days when exposed to 500 ppm, and where 300 ppm exposure for 64 weeks did not result in any apparent health effect (Smith and Von Oettingen, 1947) . In addition, a 7-d range finding study in 5 non-mated female New Zealand White rabbits showed that 7 daily exposures to a concentration of 1000 ppm were well tolerated (Theuns-van Vliet, 2016) . In the main study, each group comprised 22 mated animals and inlife parameters included mortality and morbidity, body weight, and food consumption. At gd 29 Caesarean section was performed; necropsy parameters included examination of the dams for gross anatomical changes, and for uterus and ovary weight. Some very slight maternal toxicity was noted for the 1000 ppm MeCl group, with only transient decreases in body weight (Table 4) . The number and distribution of implantation sites, live and dead fetuses, and resorptions were recorded. In addition, placentas and fetuses were weighed individually. Fetuses were examined for external and visceral malformations. Fetal hearts were examined in situ according to Staples (1974) , the same *Significantly different from control in two-tailed t-test; p < 0.05. a One dam had only one live fetus; this one was used for skeletal examination by convention. b All dams either died or were humanely sacrificed due to significant maternal toxicity. c Combined total of all identified fetal heart effects (reduced/absent papillary muscles and/or chordae tendineae; tricuspid or bicuspid valve effects).
Table 2
Observations in the hearts of mouse fetuses (Wolkowski-Tyl et al., 1983b Note: the percentages (in brackets) are added by the authors of this review. Statistical analysis (see Wolkowski-Tyl et al., 1983b ): *p < 0.05; **p < 0.01.
Table 3
Observations in the hearts of mouse fetuses in the studies by Wolkowski-Tyl et al. (1983a,b) as summarized in Tyl (1985) . (1985) . These rabbit fetuses were randomly assigned among 4-5 technicians each necropsy day and then opened in situ to evaluate the positioning of the large vessels. Special attention was paid to the valves of the heart, chordae tendineae, and papillary muscles, as these were the reported targets in mouse fetuses. No malformations of any kind, including cardiac, were observed in any exposure group; variations consisted of a blood-or fluid-filled pericardium in one control and two high concentration group fetuses, and an indentation of the heart apex in one low concentration and three high concentration group fetuses (Table 5) . Based on the limited number of affected animals, and the absence of a concentration-response relationship, these observations were not considered to be related to treatment. After visceral examination, the fetal bodies were processed and stained with Alzarin Red S for skeletal examination. Heads of half of the fetuses in each litter were fixed in Bouin's fixative for visceral head examination. Based on the absence of clinical signs, no effects on feed intake, and only a slight and transient effect on body weight in the high concentration group, the NOAEC for maternal toxicity in rabbits was identified to be ≥ 1000 ppm. Based on the complete absence of exposure-related effects on the mean number of implantation sites, early and late resorptions, live fetuses, fetus weight, and no fetal external, visceral, or skeletal observations, the NOAEC for developmental toxicity in rabbits was identified as ≥1000 ppm MeCl.
Discussion and conclusion
Based on the two studies conducted by Wolkowski-Tyl et al. (1983a,b) , the only reported effect identified in both was an effect on the tricuspid valve with as primary lesion a reduction in the number of papillary muscles. This specific effect was individually evaluated and reported in the second study with a low incidence of 3.5% at 750 ppm MeCl. The repeated exposures to this high MeCl concentration were toxic to the mouse dams, resulting in mortality (∼10%) and inducing ataxia, tremors, and convulsions in some animals and overall significantly reduced body weights and body weight gains. This specific cardiac lesion was identified at a lower incidence (1.58%) at 500 ppm, a less toxic concentration (∼10% demonstrated ataxia), and was present in both the 250 ppm (0.44%) and the control (0.46%) groups. The occurrence of a reduction in papillary muscles in controls (0.46%) further complicates the interpretation of this lesion in the 500 ppm group. Moreover, such a lesion was also reported in one control Fischer 344 rat fetus in the first study (Wolkowski-Tyl et al., 1983a) , thus suggests it to be a background lesion in both species.
It is not clear what the percentages were for this specific effect in fetal mice in the first study, as all 3 cardiac effects mentioned (a reduction or absence of the atrioventricular valves, chordae tendineae, and papillary muscles) were reported together, viz. only as a combined total number. Also, in Tyl (1985) (see Table 3 ), incidences of heart defects were combined, and Tyl did not provide any information as to which effects were seen at what incidences. In the second study, two of the effects (reduced number of chordae tendineae and the abnormal heart valve) were only seen in 2 animals each, and were not concentrationrelated, which typically would indicate that an effect may not be related to treatment. The calcinated white spots could not have been observed in the first study because of technical reasons (Bouin's fixative is a decalcifying fixative), but were seen only at a low incidence (6/844) in the second study and are possibly of a spontaneous nature (Burek et al., 1982) . Thus, except for the effect on papillary muscles, the two studies seemed to show quite variable results. In addition, the first study described a 'reduction or absence in papillary muscles' whereas the second study described only a 'reduction in the number of papillary muscles'. This aspect also opens the discussion on the biological 11.5 ± 3.5 10.7 ± 2.2 11.8 ± 1.8 10.9 ± 2.1 Implantation sites per animal 9.5 ± 3.0 10.0 ± 1.9 10.8 ± 2.0 9.9 ± 3.0 Preimplantation loss per animal 2.6 ± 2.8 1.1 ± 1.6 1.2 ± 1.3 1.3 ± 1.5 No. of fetuses per animals 8.6 ± 3.7 9.6 ± 1.8 10.4 ± 2.2 9.4 ± 3.1 % Alive 98.8 99.4 97.2 93.3 Early resorptions per animal 0.5 ± 1.6 0.1 ± 0.5 0.2 ± 0.6 0.3 ± 1.2 Late resorptions per animal 0.5 ± 0.8 0.3 ± 0.6 0.2 ± 0.4 0.3 ± 0.7 Post-implantation loss per animal 1.1 ± 1.7 0.5 ± 0.7 0.7 ± 0.9 1.2 ± 2.1 Affected implants per animal 1.1 ± 1.7 0.5 ± 0.7 0.8 ± 1.1 1.3 ± 2.1
Statistical analysis Anova-Dunnett (body weights): *p < 0.05. Data are expressed as mean ± SD. a One animal of the low concentration group was found dead on gd 26; one control animal showed complete litter loss, this pregnant animal was included for calculation.
Table 5
Overview of key results of the OECD 414 rabbit inhalation study -fetal heart variations (Theuns-van Vliet, 2016). Statistical analysis Chi-Square exact.
relevance of this effect. Whereas absence of papillary muscles would be expected to adversely affect heart valve function, it is not known how large a reduction should be in the number of papillary muscles and/or chordae tendineae to have a significant physiological impact on cardiac function. In addition, the cardiac findings in mice reported by Wolkowski-Tyl et al. (1983a,b) are tempered by significant concerns associated with both the validity of the methods used to identify the putative lesions, and the ultimate impact of those methods on the replicability/reproducibility 3 of these findings across multiple studies and investigators. John-Greene et al. (1985) challenged the ability of methods used to identify the cardiac lesions reported in Wolkowski- Tyl et al. (1983a,b) and noted that, as experience was gained in fetal evaluation in the laboratory that conducted the original study, and that once the requirement of blinded evaluation of the fetal responses was implemented, cardiac lesions were no longer evident. This conclusion regarding concerns for the replicability/reproducibility of the fetal mouse examinations is in part supported in the summary data presented by Tyl (1985) , shown in Table 3 , in which fetal cardiac responses reported in the first study (Wolkowski-Tyl et al., 1983a) shown in Table 1 were not replicated (only one of the three cardiac effects reported in the first study was noted in the second experiment); and even more importantly, also were not reproduced across the common concentration level when examinations were conducted in different laboratories. The incidence of fetuses/litter affected following 500 ppm MeCl exposure in the first study, a statistically significant 16.65%, was not statistically elevated in the second study using the same exposure concentration: 3.48% vs 0.68% fetuses/litter affected for 500 ppm and controls, respectively (Tyl, 1985) . In addition, a higher MeCl exposure (750 ppm) used in the second study resulted in a response of 5.12% fetuses/litter affected, which was substantially less than the 16.65% lesion incidence per litter reported in the first study at a lower concentration of 500 ppm.
The 750 ppm exposure was associated with significant maternal toxicity including tremors, convulsions, and increased mortality, raising questions about the reliability and usefulness of results from this concentration for hazard evaluation. The high maternal toxicity noted at 750 ppm is entirely consistent with the metabolism-based mode of action identified for systemic toxicity in mice associated with high concentration exposures to MeCl. Chellman et al. (1986) reported that pretreatment of mice with the GSH-depleting agent buthionine sulfoximine protected against high exposure MeCl-induced mortality and associated CNS toxicity (tremors, ataxia, forelimb/hindlimb paralysis), and attributed the protection to blocking formation of putative GSH-derived toxic metabolite(s).
In her comments, Tyl (1985) questioned whether the inability of John- Greene et al. (1985) to reproduce her earlier studies might have been due to differences in the testing protocols, and specifically noted that the period of gestation examined by John-Greene and co-workers, limited to gd 11.5-12.5, might not have encompassed the full gestational period of cardiac development as the formation of the atrioventricular valves commences on gd 11 and is complete only by gd 14-16 (Rugh, 1968) . Importantly, however, John-Greene et al. (1985) noted that a pilot study employing the same technician who made the original observations in the study of Wolkowski-Tyl et al. (1983a) , initially identified an increased number of cardiac lesions using the abbreviated gestational exposure protocol. The inability of subsequent experiments conducted by John-Greene and co-workers to reproduce the cardiac lesions may suggest that the initial pilot findings of John-Greene et al. (1985) , as well as those of Wolkowski-Tyl et al. (1983a,b) , were indeed due to refinements in the examination methods and/or greater experience of the laboratory technician(s) in examining fetal hearts, and thus likely may not represent a true treatment-related finding.
Thus, although both sets of authors provide arguments for their views, in the end there is high uncertainty around the objectivity (and thus reliability) of the visual interpretation of the fetal mouse heart observations. Without cross-laboratory historical data for this specific mouse model, and for the methods used to evaluate the specific cardiac effect, the biological relevance of this effect remains quite unclear.
Indeed, discussions in literature on the appropriate examination techniques of the rodent heart are not restricted to mice and MeCl. There is a wealth of published data investigating potential developmental toxicity in rodents from in utero exposure to chlorinated solvents. Trichloroethylene (TCE; C 2 HCl 3 ) provides an example that offers challenges in interpretation, similar to MeCl. Although two inhalation studies and one oral gavage study found no evidence of developmental toxicity or cardiac effects in fetal mice (Schwetz et al., 1975) or in fetal rats (Carney et al., 2006; Fisher et al., 2001) following in utero exposure to TCE, a combined dataset on drinking water exposure of pregnant rats to TCE reported fetal cardiac anomalies (Dawson et al., 1993; Johnson et al., 2003) . Subsequently, these drinking water data have been subject to several published errata and have been critiqued for inadequate experimental controls and inadequate/inappropriate statistical handling, among other issues. In fact, one such review concluded "… that the weight of experimental and epidemiologic evidence does not support the hypothesis that TCE or Dichloroethylene (C 2 H 2 Cl 2 ) is a selective developmental toxicant in general or a cardiac teratogen specifically …" (Hardin et al., 2005) . Although this endpoint was selected by EPA to support its IRIS value (US EPA, 2011), an assessment of this combined dataset by EPA staff indicated that 7 out of 11 EPA reviewers gave it a 'low' or 'moderate' rating for reliability (US EPA, 2012) . Finally, a recently published analysis of the risk of bias for the available TCE data related to fetal cardiac effects determined that the inconsistent findings in this particular study (Johnson et al., 2003 combined dataset) were likely due to limitations in study design (Wikoff et al., 2018) .
Other chlorinated solvents have been evaluated for potential developmental toxicity and provide data for structural analogues of MeCl, with no other examples of induction of fetal cardiac effects. For example, no fetal cardiac effects were seen in either Sprague Dawley rats or CF-1 mice exposed to chloroform (CHCl 3 ). In contrast, chloroform did cause teratogenic effects such as acaudia and imperforate anus in rats, and an increase in the incidence of cleft palate in mice (Schwetz et al., 1974a; Murray et al., 1979) . Other examples for chlorinated solvents include methylene chloride (CH 2 Cl 2 ), a close structural analogue of MeCl, which was tested in Sprague Dawley rats and in Swiss Webster mice with no developmental toxicity identified (Schwetz et al., 1975) . That publication also provided results on developmental toxicity for several other chlorinated solvents including TCE, perchloroethylene (C 2 Cl 4 ), and methyl chloroform (C 2 H 3 Cl 3 ); none of them exhibited any developmental toxicity. Both carbon tetrachloride (CCl 4 ) and 1,1-dichloroethane (C 2 H 4 Cl 2 ) were tested in Sprague Dawley rats with no developmental effects identified (Schwetz et al., 1974b) . Ethyl chloride (C 2 H 5 Cl), another close analogue of MeCl, was tested for developmental toxicity in mice and was found to be not teratogenic even at 5000 ppm (Hanley et al., 1987) . Thus, among all the structural analogues of these chlorinated solvents, MeCl is the only one with fetal cardiac effects reported in the mouse; the fetal cardiac effects reported in only one dataset for TCE in the rat are not reproducible nor supported by reliable data. And, while chloroform is classified under GHS as a developmental toxicant Cat. 2 (H361d), this classification is not based on fetal cardiac lesions.
Despite the high uncertainty and lack of reproducibility and replicability, Wolkowski-Tyl et al. (1983a) had suggested that the cardiac lesion observed in mice appeared similar to Ebstein's anomaly in humans. Ebstein's anomaly is a congenital heart defect in which the septal and posterior leaflets of the tricuspid valve are displaced downward, towards the apex of the right ventricle of the heart, resulting in a small right ventricular chamber (Bankl, 1977) . A small right ventricle was reported in only one fetus each from the 500 and 750 ppm MeCl groups (Wolkowski-Tyl et al., 1983b) , and was not identified in any fetus of any exposure group in their first dataset, including not at 500 ppm (Wolkowski-Tyl et al., 1983a) ; so it is not at all clear that this effect from the second dataset is treatment-related. In humans, Ebstein's anomaly usually occurs in conjunction with severe obstructive anomalies of the pulmonary valve or an interatrial communication, and sometimes in conjunction with a ventricular septal defect (John-Greene et al., 1985) , which makes it a significant lesion with severe physiological impact. As such, John-Greene et al. (1985) concluded that specific alterations of the papillary muscles in the absence of anomalies of the ventricular septum or great vessels are uncommon in humans and rodents as well, further mitigating any likely impact or human relevance of this non-reproducible cardiac lesion. Moreover, Xanthos et al. (2011) also noted that the number, length, and shape of the papillary muscles and chordae tendineae are variable in humans.
The current report provides results from the first non-rodent developmental toxicity study on MeCl, conducted in 2015 as a GLP, OECD 414 guideline study (Theuns-van Vliet, 2016) . The study showed that exposure of rabbits to 0, 250, 500, or 1000 ppm MeCl did not induce any developmental toxicity. Given the cardiac lesions reported in fetal mice, the hearts of these fetal rabbits were carefully and thoroughly examined according to Staples (1974) (fresh tissue), as required by the OECD 414 guideline. The larger size of the rabbit fetal heart offered a significant advantage to conduct a detailed in situ evaluation using a stereomicroscope, and allowed for a clear conclusion of no developmental toxicity and specifically no cardiac effects induced in rabbit fetuses following repeated inhalation in utero exposures to MeCl.
Integrating the new developmental data with a third species (rabbit) into the overall hazard assessment for developmental toxicity (data overview shown in Table 6 ) leads to the following conclusions:
1. The normal anatomy of the tiny papillary muscles in the fetal mouse heart and the variability of their appearance as observed by JohnGreene et al. (1985) complicate any evaluation. This variability may be considered normal in humans, as the number, length, and shape of these muscles are variable (Xanthos et al., 2011) . 2. It was noted that MeCl showed much higher maternal toxicity in mice than in rats or rabbits. Rats showed some maternal toxicity at 1500 ppm (not at 500 ppm), and rabbits showed only slight toxicity at 1000 ppm (and not at 500 ppm). Mice, in contrast, in the first study had to be humanely sacrificed at 1500 ppm, and showed severe toxicity at 750 ppm in the second study, including 10% mortality. Thus pregnant mice of this non-standard strain are more susceptible than pregnant rats or pregnant rabbits to the systemic (mostly CNS) toxicity of MeCl, which is most probably due to a species difference in metabolism at higher concentrations. 3. MeCl is extensively metabolized in Phase I and II in various tissues and appears to have species-specific metabolic characteristics (Dekant et al., 1995; US EPA, 2001) . Typically, when metabolic activation contributes significantly to a mode of action for other endpoints, it is difficult to define the best animal model to predict human relevance for a specific endpoint. Therefore, in 2010 with no further data in an additional species, it was prudent to propose a self-classification based on conflicting data in rats and mice, notwithstanding the doubts expressed by various experts and regulatory bodies regarding the relevance and reproducibility/replicability of the reported fetal mouse data, generating considerable uncertainty (John-Greene et al., 1985; Dutch Health Council, 2004) . 4. Consideration that the mouse strain showing the developmental heart effects is not commonly used for developmental toxicity testing complicates the interpretation of its relevance, and adds to the uncertainty already present due to the low incidences and lack of reproducibility/replicability of the effects observed, along with a lack of historical control data for these lesions. Consulting experts on reproductive/developmental toxicity indicated that the kind, number, and degree of the heart effects reported in these fetal mice, if not an artifact due to the large inter-animal variability, may also be related to the technical difficulty to perform these examinations in such small subjects.
In view of the now available OECD 414 guideline GLP study in a standard non-rodent species and strain (New Zealand White rabbit), the negative fetal rat data, and in consideration of the remaining questions and uncertainties surrounding the fetal mouse data, the scientific weight of the mouse data is extremely limited.
Although not completely refuted, in view of the general uncertainty accepted under EU REACh for developmental toxicity data on industrial chemicals (data for a rodent and non-rodent species if production is above 1000 tonnes), weighing all scientific information would not lead to a decision to base a classification for developmental toxicity on the available fetal mouse data. Indeed, all scientific evidence points towards the lack of developmental toxicity in two well-conducted studies in two species (rat and rabbit), and is further supported by the John- Greene et al. (1985) data and observations vis-à-vis the fetal mouse data.
Thus, in agreement with the conclusions of the Working Group "Classification and labelling of dangerous substances" and under the new chemical legislation, i.e. REACh and CLP, it is therefore reasonable and prudent to consider that MeCl no longer meets the classification criteria for developmental toxicity. This change is supported by the significantly increased quality of the overall database, with an additional negative dataset from a third (non-rodent) species, and by an evaluation of the available scientific evidence, which does not support classification of MeCl as a developmental toxicant. 
